Microparticles: Major transport vehicles for distinct microRNAs in circulation

Cardiovascular Research

Volumn 93, Issue 4, 2012, Pages 633-644

  Diehl, Philipp ^a,b   Fricke, Alba ^a   Sander, Laura ^a   Stamm, Johannes ^a   Bassler, Nicole ^a   Htun, Nay ^a,b   Ziemann, Mark ^a   Helbing, Thomas ^c   El Osta, Assam ^a,b   Jowett, Jeremy B M ^a,d   Peter, Karlheinz ^a,b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Microparticles; MicroRNA; Vascular inflammation

Indexed keywords

MICRORNA;

ACUTE CORONARY SYNDROME; AGED; CARDIOVASCULAR DISEASE; CELL VACUOLE; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RNA ANALYSIS; RNA TRANSPORT;

AGED; BIOLOGICAL MARKERS; BIOLOGICAL TRANSPORT; BLOOD PLATELETS; CELL-DERIVED MICROPARTICLES; CELLS, CULTURED; CORONARY ARTERY DISEASE; ENDOTHELIUM, VASCULAR; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LIPOPOLYSACCHARIDES; MALE; MICRORNAS; MIDDLE AGED; MONOCYTES; SEVERITY OF ILLNESS INDEX; TETRADECANOYLPHORBOL ACETATE;

EID: 84857975438     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs007     Document Type: Review

References (53)

1. Hugel B, Martinez MC, Kunzelmann C, Freyssinet JM. Membrane microparticles: two sides of the coin. Physiology (Bethesda) 2005;20:22-27. (Pubitemid 40363367)
2. Prokopi M, Pula G, Mayr U, Devue C, Gallagher J, Xiao Q et al. Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood 2009;114:723-732.
3. Mause SF, Weber C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 2010;107:1047-1057.
4. Distler JH, Pisetsky DS, Huber LC, Kalden JR, Gay S, Distler O. Microparticles as regulators of inflammation: novel players of cellular crosstalk in the rheumatic diseases. Arthritis Rheum 2005;52:3337-3348. (Pubitemid 41612200)
5. Shantsila E, Kamphuisen PW, Lip GY. Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis. J Thromb Haemost 2010;8:2358-2368.
6. VanWijk MJ, VanBavel E, Sturk A, Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc Res 2003;59:277-287. (Pubitemid 37272022)
7. Ratajczak J, Miekus K, Kucia M, Zhang J, Reca R, Dvorak P et al. Embryonic stem cellderived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 2006;20:847-856.
8. Cai X, Hagedorn CH, Cullen BR. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. Rna 2004;10: 1957-1966. (Pubitemid 39557833)
9. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005;120:15-20. (Pubitemid 40094598)
10. Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk RH, Cuppen E. Phylogenetic shadowing and computational identification of human microRNA genes. Cell 2005;120:21-24. (Pubitemid 40094599)
11. Urbich C, Kuehbacher A, Dimmeler S. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res 2008;79:581-588.
12. Gupta SK, Bang C, Thum T. Circulating microRNAs as biomarkers and potential paracrine mediators of cardiovascular disease. Circ Cardiovasc Genet 2010;3:484-488.
13. Bauersachs J, Thum T. Biogenesis and regulation of cardiovascular microRNAs. Circ Res 2011;109:334-347.
14. Fichtlscherer S, Zeiher AM, Dimmeler S. Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? Arterioscler Thromb Vasc Biol 2011;31:2383-2390.
15. Hartmann D, Thum T. MicroRNAs and vascular (dys)function. Vascul Pharmacol 2011; 55:92-105.
16. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C et al. Circulating microRNAs in patients with coronary artery disease. Circ Res 2010;107:677-684.
17. Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He J et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 2010;31:659-666.
18. Kozomara A, Griffiths-Jones S. miRBase: integrating microRNA annotation and deepsequencing data. Nucleic Acids Res 2011;39:D152-D157.
19. Mar JC, Kimura Y, Schroder K, Irvine KM, Hayashizaki Y, Suzuki H et al. Data-driven normalization strategies for high-throughput quantitative RT-PCR. BMC Bioinformatics 2009;10:110.
20. Yuana Y, Bertina RM, Osanto S. Pre-analytical and analytical issues in the analysis of blood microparticles. Thromb Haemost 2011;105:396-408.
21. Morel O, Hugel B, Jesel L, Mallat Z, Lanza F, Douchet MP et al. Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonists. J Thromb Haemost 2004;2:1118-1126. (Pubitemid 40186085)
22. Hurd PJ, Nelson CJ. Advantages of next-generation sequencing versus the microarray in epigenetic research. Brief Funct Genomic Proteomic 2009;8:174-183.
23. Zhang J, Chiodini R, Badr A, Zhang G. The impact of next-generation sequencing on genomics. J Genet Genomics 2011;38:95-109.
24. Bakouboula B, Morel O, Faure A, Zobairi F, Jesel L, Trinh A et al. Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertension. Am J Respir Crit Care Med 2008;177:536-543. (Pubitemid 351442193)
25. Lynch SF, Ludlam CA. Plasma microparticles and vascular disorders. Br J Haematol 2007;137:36-48. (Pubitemid 46426401)
26. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007;9:654-659. (Pubitemid 47214727)
27. Chen TS, Lai RC, Lee MM, Choo AB, Lee CN, Lim SK. Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs. Nucleic Acids Res 2010;38: 215-224.
28. Stein JM, Luzio JP. Ectocytosis caused by sublytic autologous complement attack on human neutrophils. The sorting of endogenous plasma-membrane proteins and lipids into shed vesicles. Biochem J 1991;274:381-386.
29. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, Yu L et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 2008;3:e3694.
30. De Rosa S, Fichtlscherer S, Lehmann R, Assmus B, Dimmeler S, Zeiher AM. Transcoronary concentration gradients of circulating microRNAs. Circulation 2011;124: 1936-1944.
31. Villar AV, Merino D,Wenner M, Llano M, Cobo M, Montalvo C et al. Myocardial gene expression of microRNA-133a and myosin heavy and light chains, in conjunction with clinical parameters, predict regression of left ventricular hypertrophy after valve replacement in patients with aortic stenosis. Heart 2011;97:1132-1137.
32. Gabbasov Z, Parfyonova Y, Popov E, Gavrilov I, Anuchin V, Dubov P et al. Association of platelet function in hypertensive patients with left ventricular hypertrophy, transient myocardial ischemia, and coronary artery disease. Platelets 1998;9:191-195. (Pubitemid 28312678)
33. D'Alessandra Y, Devanna P, Limana F, Straino S, Di Carlo A, Brambilla PG et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J 2010;31:2765-2773.
34. Sayed D, Hong C, Chen IY, Lypowy J, Abdellatif M. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 2007;100:416-424.
35. Doebele C, Bonauer A, Fischer A, Scholz A, Reiss Y, Urbich C et al. Members of the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells. Blood 2010;115:4944-4950.
36. Chen Y, Gorski DH. Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood 2008;111: 1217-1226. (Pubitemid 351213403)
37. Leroyer AS, Rautou PE, Silvestre JS, Castier Y, Leseche G, Devue C et al. CD40 ligand + microparticles from human atherosclerotic plaques stimulate endothelial proliferation and angiogenesis a potential mechanism for intraplaque neovascularization. J Am Coll Cardiol 2008;52:1302-1311.
38. Ren XP,Wu J,Wang X, Sartor MA, Qian J, Jones K et al. MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein. Circulation 2009;119:2357-2366.
39. Thum T, Galuppo P,Wolf C, Fiedler J, Kneitz S, van Laake LWet al. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 2007;116: 258-267. (Pubitemid 47196561)
40. Tijsen AJ, Creemers EE, Moerland PD, de Windt LJ, van der Wal AC, Kok WE et al. MiR423-5p as a circulating biomarker for heart failure. Circ Res 2010;106: 1035-1039.
41. Kumarswamy R, Anker SD, Thum T. MicroRNAs as circulating biomarkers for heart failure: questions about MiR-423-5p. Circ Res 2010;106:e8; author reply e9.
42. Sarkar J, Gou D, Turaka P, Viktorova E, Ramchandran R, Raj JU. MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migration. Am J Physiol Lung Cell Mol Physiol 2010;299:L861-871.
43. Zhou J,Wang KC, WuW, Subramaniam S, Shyy JY, Chiu JJ et al. MicroRNA-21 targets peroxisome proliferators-activated receptor-alpha in an autoregulatory loop to modulate flow-induced endothelial inflammation. Proc Natl Acad Sci USA 2011;108: 10355-10360.
44. Kumarswamy R, Volkmann I, Jazbutyte V, Dangwal S, Park DH, Thum T. Transforming Growth Factor-beta-Induced Endothelial-to-Mesenchymal Transition Is Partly Mediated by MicroRNA-21. Arterioscler Thromb Vasc Biol 2012;32:361-369.
45. Bandres E, Bitarte N, Arias F, Agorreta J, Fortes P, Agirre X et al. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clin Cancer Res 2009;15:2281-2290.
46. Garner LB, Willis MS, Carlson DL, DiMaio JM, White MD, White DJ et al. Macrophage migration inhibitory factor is a cardiac-derived myocardial depressant factor. Am J Physiol Heart Circ Physiol 2003;285:H2500-H2509. (Pubitemid 37443067)
47. Ikeda S, Kong SW, Lu J, Bisping E, Zhang H, Allen PD et al. Altered microRNA expression in human heart disease. Physiol Genomics 2007;31:367-373. (Pubitemid 350127777)
48. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008;456:980-984.
49. Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M et al. Plasma micro-RNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 2010;107:810-817.
50. Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, Hofstra L et al. Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet 2010;3:499-506.
51. Takahashi Y, Satoh M, Minami Y, Tabuchi T, Itoh T, Nakamura M. Expression of miR-146a/b is associated with the Toll-like receptor 4 signal in coronary artery disease: effect of renin-angiotensin system blockade and statins on miRNA-146a/b and Toll-like receptor 4 levels. Clin Sci (Lond) 2010;119:395-405.
52. Landry P, Plante I, Ouellet DL, Perron MP, Rousseau G, Provost P. Existence of a microRNA pathway in anucleate platelets. Nat Struct Mol Biol 2009;16:961-966.
53. Lu Y, Zhang Y, Wang N, Pan Z, Gao X, Zhang F et al. MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. Circulation 2010; 122:2378-2387.